The DOI matches its Crossref record; 182 of the 185 references it cites were found in a registry or an index.
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Open accessAbstract
The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2 family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic apoptotic response. Recent advances in our understanding of apoptotic signaling pathways have enabled methods to identify cancers that are “primed” to undergo apoptosis, and have revealed potential biomarkers that may predict which cancers will undergo apoptosis in response to specific therapies. Complementary efforts have focused on developing novel drugs that directly target antiapoptotic BCL2 family proteins. In this review, we summarize the current knowledge of the role of BCL2 family members in cancer development and response to therapy, focusing on targeted therapeutics, recent progress in the development of apoptotic biomarkers, and therapeutic strategies designed to overcome deficiencies in apoptosis. Significance: Apoptosis, long known to be important for response to conventional cytotoxic chemotherapy, has more recently been shown to be essential for the efficacy of targeted therapies. Approaches that increase the likelihood of a cancer to undergo apoptosis following therapy may help improve targeted treatment strategies. Cancer Discov; 5(5); 475–87. ©2015 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inhibition of MEK/ERK signaling leads to BIM accumulation and increases apoptotic priming in oncogene-driven cancers treated with various targeted therapies, driving cells into an MCL-1 and/or BCL-XL dependent state15,17.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Suppression of MEK/ERK signaling leads to the accumulation of the pro-apoptotic BCL-2 family protein BIM, which is critical for inducing apoptosis in response to an array of targeted therapies14,15.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [15]
In the citing paper
“Many studies have established a central role of the pro-apoptotic BH3 protein BIM in mediating the apoptotic response to targeted therapies (reviewed in [116]).”
From Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer (2021) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477
Self-citation
Cited by
Sorted by citations
Items 501–600 of 625
Expression of Apoptotic Proteins Bax and Bcl-2 in Blood Cells of Type 2 Diabetic Patients
Özkorkmaz, E. G., KİRMAN, G., Pekkolay, Z., Aşir, F., & Devecí, E. (2018) · International Cell Death Research Congress · doi:10.3390/proceedings2251563 · Cited by 2
Potential anticancer effect of sodium caprate on human gastric cancer cells
Kim, N. H., Park, J. H., Koo, D., Lee, T., Yang, J.-Y., & Lee, H. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221119182 · Cited by 2
Hanif, M. M., Tjong, D. H., Syaifullah, S., Santoso, P., Efrizal, E., & Roesma, D. I. (2022) · Malaysian Applied Biology · doi:10.55230/mabjournal.v51i3.2283 · Cited by 2
Azmat, H., Faridi, J., Habib, H. M., Bugti, U. J., Sheikh, A. K., & Riaz, S. K. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_735_20 · Cited by 2
Khan, A. Y. F., Wahab, R. A., Ahmed, Q. U., Khatib, A., Ibrahim, Z., Nipun, T. S., Nawawi, H. M., Azmi, S. N. H., Sarker, M. Z. I., Zakaria, Z. A., et al. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102727 · Cited by 2
El-Khawanky, M. M., Morsy, M. H., Elnaggar, A., Hussin, O., Zaewer, M., & Khalifa, N. (2019) · Journal of Applied Hematology · doi:10.4103/joah.joah_5_19 · Cited by 2
Espadinha, M., Conway, S. J., & Santos, M. M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818349-6.00010-8 · Cited by 2
Pulling the BAX trigger for tumor cell death
Reyna, D. E., & Gavathiotis, E. (2018) · Oncotarget · doi:10.18632/oncotarget.24201 · Cited by 2
FNC Inhibits Proliferation and Metastasis of Non-Small-Cell Lung Cancer in Vivo and In VitroPreprint
Xiang, J., Niu, S., Liang, Y., Chen, H., Wang, N., Peng, Y., Ma, F., Yue, W., Wang, Q., Chang, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-219276/v1 · Cited by 2
Gola, J. M., Simka-Lampa, K., Strzałka‐Mrozik, B., Kruszniewska‐Rajs, C., Gagoś, M., & Mazurek, U. M. (2018) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/76048 · Cited by 1
Kalashnyk-Vakulenko, Y. M., Губіна-Вакулик, Г. І., Onishchenko, A. I., Наконечна, О. А., Gorbach, T. V., Tkachenko, V., & Tkachenko, A. S. (2022) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/12689 · Cited by 1
Zhang, Y., Wu, W., Shi, Y., Huang, Y., Dai, T., Ke, L., Chen, L., Chen, M., & Wang, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413440 · Cited by 1
IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia
Nagel, S., Meyer, C., & Pommerenke, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315196 · Cited by 1
Yang, Z., Mogre, S., Jun, H., He, R., Chaudhary, S. G., Bhattarai, U. R., Sui, S. J. H., Matulonis, U. A., Lazo, S., Shetty, A., et al. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0028 · Cited by 2
Aldhahrani, A., Binjawhar, D. N., Katouah, H. A., Albaqami, J. J., Elsaid, F. G., Fayad, E., Almaaty, A. H. A., & El-Zend, M. A. (2025) · Journal of Cluster Science · doi:10.1007/s10876-025-02854-7 · Cited by 1
Liu, L., He, T., Zhang, Z., Dai, W., Ding, L., Hong, Y., Xu, B., Shang, Y., Deng, Y., Fu, X., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157252 · Cited by 1
Kılıçcıoğlu, İ., Dulger, G., Musatat, A. B., Atahan, A., Çalışkan, E., Alpay, M., Zengin, M., & Dülger, B. (2025) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05360-8 · Cited by 1
Jaganathan, S. S., Natarajan, U., & Rathinavelu, A. (2025) · Epigenomics · doi:10.1080/17501911.2025.2558497 · Cited by 1
Xu, Z., Sun, S., Gao, H., Feng, R., & Shen, X. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.110 · Cited by 1
Intrinsic NPRL2 and NPRL3 regulate the sensitivity of B-cell malignancies to CAR-T cell therapy.
Han, F., Lu, Y.-T., Zhang, Y.-P., Ma, X., Tong, C., Wei, J.-S., Guo, Y.-L., Liu, C., Wu, Z.-Q., Han, W.-D., et al. (2025) · Journal of genetics and genomics = Yi chuan xue bao · doi:10.1016/j.jgg.2025.11.007 · Cited by 1
Dynamical analysis of a model of BCL-2-dependent cellular decision making
Cloete, I., & Alarcón, T. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00615-w · Cited by 1
Yadav, M., Dahiya, M., Chauhan, S., Sharma, S., Rabbani, S. A., Senwar, K. R., Dhillon, A., & Kumar, S. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100264 · Cited by 1
Carrasco, I. L. L., Gómez-Castro, C. Z., Zárate-Hernández, L. Á., Camacho-Mendoza, R. L., Montiel, S. G., Franco‐Pérez, M., & Cruz‐Borbolla, J. (2026) · Organic & Biomolecular Chemistry · doi:10.1039/d5ob02005k · Cited by 1
Rather, A. A., Halikar, A. M., Sachdeva, R., Tiwari, S. K., & Santhoshkumar, T. R. (2026) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2026.118471 · Cited by 1
Cheng, J., Wang, H., Zhang, Y., & Liu, G. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117802 · Cited by 1
Guo, X., Zhou, L., Buerliesi, A., Ye, J., Lv, Y., Wei, W., Jiao, J., Ge, W., Zhu, Y., & Zhang, W. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s570540 · Cited by 1
Zhang, M., Zhang, Y., Shen, F., Yan, M., Cheng, P., Teng, J., Zou, M., Yao, W., Wang, Z., & Li, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761280 · Cited by 1
Bozhdansky, V., Tayar, S., Kashkash, S., Bacharach, E., & Ehrlich, M. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02823-1 · Cited by 1
Malik, A., Yadav, M., Kadian, J. P., Mishra, K., Ramsha, Rathore, A., Manisha, & Rathour, N. (2026) · Medicinal Chemistry Research · doi:10.1007/s00044-026-03607-5 · Cited by 1
Sensitivity and Resistance to BH3 Mimetics in Cancer Therapy
Floros, K. V., Faber, A. C., & Harada, H. (2018) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-67932-7_7 · Cited by 1
Self-citationChoi, Y. H., Kim, M., Hwangbo, H., Choi, E., Kwon, D. H., Ahn, K. I., Ji, S., Jeong, J.-W., Hong, S. H., & Park, C. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_484_17 · Cited by 1
Zeng, X., Lv, H., & Huang, X. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i6.9 · Cited by 1
Justaud, F., Paysant, H., Weiswald, L., Jebahi, A., Jouanne, M., Elie, N., Voisin‐Chiret, A. S., Roisnel, T., Orione, C., Levoin, N., et al. (2022) · New Journal of Chemistry · doi:10.1039/d1nj05987d · Cited by 1
B-cell lymphoma 2 family members and sarcomas: a promising target in a heterogeneous disease
Oliveira, R. C., Gama, J. M., & Casanova, J. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00154 · Cited by 1
Protective effect of propolis on cadmium chloride induced toxicity in male Japanese quails
Rashad, E. N. (2022) · International Journal of Advanced Scientific Research and Innovation · doi:10.21608/ijasri.2022.337230 · Cited by 1
Hoang, V. H., Hương, L. T., Tâm, K. T., Le, T. N. T., Nguyen, T. K. O., & Nguyen, P. H. (2025) · RSC Advances · doi:10.1039/d5ra03268g · Cited by 1
Supraptiningsih, E. S., Nugroho, S., & Wahyuni, E. S. (2019) · majalah kesehatan · doi:10.21776/ub.majalahkesehatan.2019.006.04.2 · Cited by 1
Fuzzy Predictions Regarding In Vitro Behavior of Cells Line Under Cytostatic Treatment
Caramihai, M. D., Radu, N., Bostan, M., Ion, G., Chirvase, A. A., Constantin, M., Doni, M., & Babeanu, N. E. (2019) · E-Health and Bioengineering Conference (EHB) · doi:10.1109/ehb47216.2019.8970088 · Cited by 1
Mitochondria and Their Cell Hosts: Best of Frenemies
Andres, A. M., Pourpirali, S., & Gottlieb, R. A. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-78799-8_10 · Cited by 1
Barua, A., Choudhury, P., Panda, C. K., & Saha, P. (2022) · Current Science · doi:10.18520/cs/v122/i4/429-438
Targeting eIF5A2 reduces invasion and reverses chemoresistance in SCC-9 cells in vitro.
Gao, J., & Li, P. (2024) · PubMed · doi:10.14670/hh-18-637 · Cited by 1
Xu, L., Mu, J., & Meng, X. (2021) · Research Square · doi:10.21203/rs.3.rs-287087/v1 · Cited by 1
Anticancer effects of Bifidobacteria on colon cancer cell linesPreprint
Faghfoori, Z., Faghfoori, M. H., Saber, A., Izadi, A., & Khosroushahi, A. Y. (2021) · Research Square · doi:10.21203/rs.3.rs-120251/v2 · Cited by 1
LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS -mutant lung cancersPreprint
Li, C., Syed, M. U., Nimbalkar, A., Shen, Y., Fraser, C., Inde, Z., Qin, X., Ouyang, J., Kreuzer, J., Clark, S. E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.29.510137 · Cited by 1
Self-citationEnergy Landscape near Glioma Decipher the Role of Glioma Stem Cells within Glioma HierarchyPreprint
Yao, M., Su, Y., Xiong, R., Zhang, X., Xiao-mei, Z., Chen, Y.-C., & Ao, P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.24.568616 · Cited by 1
Barra, C. N. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2016.tde-27102015-111101
BCL-2 Proteins and their Role in Cancer Resistance
Thakur, H., & Mattoo, A. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_21
In SilicoDesigning a Novel Multi-epitope DNA Vaccine against Anti-apoptotic Proteins in Tumor Cells
Mahmoodi, S., & Nezafat, N. (2018) · Current Proteomics · doi:10.2174/1570164616666181127142214
Ishida, C. T., Zhang, Y., Bianchetti, E., Shu, C., Sanchez‐Quintero, M. J., Quinzii, C. M., Westhoff, M., Karpel‐Massler, G., Canoll, P., & Siegelin, M. D. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3195357
Wahab, S. (2019) · International Journal of Medical Reviews and Case Reports · doi:10.5455/ijmrcr.topical-cocoa-skin-cancer
Samuel, P. (2019) · Radar (Oxford Brookes University) · doi:10.24384/bhrw-wn75
Protection from Endoplasmic Reticulum Stress and Apoptosis via PPARδ and Bcl-2 in Breast Cancer
Wong, H. (2019) · TSpace (University of Toronto)
Obesity-induced hepatic changes during pregnancy
Grilo, L. F. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Harman, J. R., Thorne, R., Jamilly, M., Tapia, M. C., Crump, N. T., Rice, S., Beveridge, R. D. D., Morrissey, E. R., Bruijn, M. F. T. R. D., Roberts, I. A. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.30.179796
GC-MS Analysis and Computational Studies of Roots of Anthocephalus Cadamba
Sruthi, K. S., & Adikay, S. (2020) · Learning and analytics in intelligent systems · doi:10.1007/978-3-030-46939-9_50
Fundamental Studies of the Effect of Plasma on Plasmid DNA, Cancer Cells, and Virus
Yan, X., & Lu, X. (2020) · Springer series on atomic, optical, and plasma physics · doi:10.1007/978-3-030-49966-2_10
Zawam, H., Ibrahim, N. E., Salama, R. A. A., Samir, M., Abdelfattah, W., Demerdash, D. M. E., Sabry, D., Tabak, S. A., & Khairy, R. A. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.5697
A precision approach to breast cancer treatment based on cell lineage-specific vulnerabilities
Desgrosellier, J. S. (2021) · Oncoscience · doi:10.18632/oncoscience.538
핵산합성 억제제인 decitabine과 NF-κB 활성 저해제인 PDTC의 병용 처리에 의한 인체 위암세포사멸 효과 증진
최원경, & Choi, Y. H. (2018) · JoLS Journal of Life Sciences
Wang, P., Hu, G., Zhao, W., Du, J., You, M., Xv, M., Yang, H., Zhang, M., Yan, F., Huang, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1000478/v1
Shi, Y., Ye, J., Shen, H., Xu, Y., Wan, R., Ye, X., Jin, J., & Xie, W. (2021) · Research Square · doi:10.21203/rs.3.rs-1013076/v1
Impresionismo de pintores rusos
Angulo, J. S., & Ramos, M. Á. (1997) · Galería Antiqvaria: Arte contemporáneo, antigüedades, mercado, coleccionismo
Shan, K. P., Saptarini, N. M., & Levita, J. (2017) · Pharmacology and Clinical Pharmacy Research · doi:10.15416/pcpr.v2i2.15209
Anticancer Effects of Bifidobacteria on Colon Cancer Cell LinesPreprint
Faghfoori, Z., Faghfoori, M. H., Saber, A., Izadi, A., & Khosroushahi, A. Y. (2020) · Research Square · doi:10.21203/rs.3.rs-120251/v1
Novel Natural-based Biomolecules Discovery for Tackling Chronic Diseases
Kwok, H. F. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0387-5
Liang, H., Wen, Y., Fang, W., Cai, X., Wang, X., Li, Z., Wei, P., Yang, B., Lu, J., Yang, Y., et al. (2022) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.56.4.192
de Pontes, C. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2021.tde-16022022-121208
Epithelial-mesenchymal transition and resistance to EGFR inhibitors
Jacob, S., Kurupi, R., & Faber, A. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822833-3.00009-7
Self-citationLeto, S. M., Ferri, M., Sassi, F. P., Zanella, E. R., Cottino, F., Vurchio, V., Catalano, I., Ferrero, A., Zingaretti, C. C., Marchiò, C., et al. (2023) · doi:10.1158/1078-0432.c.6533128.v1
Dalton, K. M., Krytska, K., Lochmann, T. L., Sano, R., Casey, C., D'Aulerio, A., Khan, Q. A., Crowther, G. S., Coon, C. M., Cai, J., et al. (2023) · doi:10.1158/1535-7163.22522659.v1
Self-citationDalton, K. M., Krytska, K., Lochmann, T. L., Sano, R., Casey, C., D'Aulerio, A., Khan, Q. A., Crowther, G. S., Coon, C. M., Cai, J., et al. (2023) · doi:10.1158/1535-7163.c.6543453.v1
Self-citationHamdin, C. D., Muliasari, H., Dewi, N. M. A. R., & Puspitasari, C. E. (2023) · AIP conference proceedings · doi:10.1063/5.0123143
Robert, J. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77967-1.00014-0
Anti-cancer effects of renieramycin T on human non-small cell lung cancer cells
Petsri, K. (2019) · Chula Digiverse · doi:10.58837/chula.the.2019.423
In the Pipeline: Emerging Therapy for CML
Gill, H., Lee, E., & Mo, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-3810-0_52
Proteomic Stratification of Prognosis and Treatment Options for Small Cell Lung CancerPreprint
Huo, Z., Duan, Y., Zhan, D., Xu, X., Zheng, N., Cai, J., Sun, R., Wang, J., Cheng, F., Gao, Z. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.22.563494
Universiti Teknologi, M. A. R. A., Khan, A. Y. F., Ahmed, Q. U., Khatib, A., Ibrahim, Z., Nipun, T. S., Natto, H. A., Saiman, M. Z., Malaya, U. O., Zakaria, Z. A., et al. (2023) · Boletin Latinoamericano y del Caribe de plantas Medicinales y Aromaticas · doi:10.37360/blacpma.24.23.1.4
Jiang, H., Yuan, Q., Chu, Y., Li, Y., Zhu, M., & Li, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4133300/v1
Gülçiçek, O. B., Oran, D. S., Temizyürek, A., Yavuz, E., Yiğitbaş, H., Erçetin, C., Solmaz, A., Yıldırım, F., Sönmez, K., & Çelik, A. (2024) · European Journal of Cancer Care · doi:10.1155/2024/5871444
Kianfar, T., Hasan, R., Azizi, Y., & Ramezani, F. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328313815240723044625
Tandon, A., & Stern, J. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.18.619052
You, T., Peng, K., Yi, J., Du, Y., Jiang, P.-Y., Zeng, D., Wu, J., Liu, J., & Wu, S.-J. (2024) · Shock · doi:10.1097/shk.0000000000002504
Talapphet, N., & Kim, M. (2025) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683824604840
Role of erythrocyte Gq protein in tumor metastasis
Vučetić, A. (2025) · doi:10.21248/gups.91215
Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasms
Sukrithan, V., Ahmed, U., Krause, H. B., Gandhi, N. S., Elliott, A., Hinton, A. C., Walker, P., Vanderwalde, A. M., Zhou, Y. H., Patel, D. C., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0341
Tandon, A., & Stern, J. L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322961
Harisa, G. I., Omran, G. A., Noureldin, M., Noreldin, A. E., Alshehri, S., Rashid, S. A., & Okda, T. M. (2025) · European Journal of Chemistry · doi:10.5155/eurjchem.16.2.222-232.2641
Mao, X.-H., Mao, X., Huang, H., Zhao, L., Zhou, T., Han, J., Yuan, X., Li, F., Wang, Z., Liang, S., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109841
Imtiyaz, K., Shafi, M., Mirza, B., & Rizvi, M. M. A. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100347
Elumalai, M., Nagaraj, G., Ramaraj, S. G., Vellaichamy, E., Tabata, H., & Rajendiran, N. (2025) · Dalton Transactions · doi:10.1039/d5dt01825k
miR-153 Overexpression and BCL2 Targeting Induce Apoptosis and Autophagy in HepG2 Cells
Nafar, S., Fallahi, J., Moradi, S., Tamaddon, G., & Tabei, K. (2025) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-025-01343-y
Synergistic targeting of MCL1 and caspases for enhanced anti-tumor immunity in breast cancerPreprint
Yi, J. K., Lee, J., Kim, P., Shaw, L. M., & Spektor, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681458
A Review of Recent Developments in Schiff Base Derivatives for Cancer Treatment
Ngu, C. P., Sahu, R., Shah, K., Paliwal, D., Sah, A. K., & Thakur, A. (2025) · Current Organic Chemistry · doi:10.2174/0113852728405259250924102913
LRRN3 protects dopaminergic neurons by inhibiting glycolysis in Parkinson’s disease
Gao, J., Qin, K., Xian, W., Ren, J., Xie, A., & Hou, B. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150119
Müller, D., Mazzeo, P., Koch, R., Bösherz, M.-S., Welter, S., von Hammerstein-Equord, A. F., Hinterthaner, M., Cordes, L., Belharazem, D., Marx, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17020815
Müller, D., Mazzeo, P., Koch, R., Bösherz, M.-S., Welter, S., von Hammerstein-Equord, A. F., Hinterthaner, M., Cordes, L., Belharazem, D., Marx, A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17020809
Metadata
- Authors
- Hata, A. N., Engelman, J. A., & Faber, A. C.
- Affiliations
- Harvard University (US)
- Virginia Commonwealth University (US)
- Corresponding author
- Engelman, Jeffrey A.
- Faber, Anthony C.
- Venue
- Cancer Discovery
- Published
- 2015-05-01
- Volume
- 5
- Issue
- 5
- Pages
- 475-487
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC4727530
- OpenAlex
- W2067275727
- Cited by
- 619
- References
- 185
- Citations by year
- 2026: 19 · 2025: 48 · 2024: 46 · 2023: 42 · 2022: 69 · 2021: 79 · 2020: 83 · 2019: 79 · 2018: 73 · 2017: 45 · 2016: 29 · 2015: 6
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50CA127003, R01CA140594, R01CA164273, R01CA137008)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Bcl-2 family proteins, apoptosis, targeted cancer therapy, mitochondrial apoptosis, cancer therapy response, carcinogenesis, apoptosis resistance
- MeSH terms
- Bcl-2-Like Protein 11, Animals, Antineoplastic Agents, Humans, Membrane Proteins, Neoplasms, Proto-Oncogene Proteins, Signal Transduction, Biomarkers, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review